Company Filing History:
Years Active: 2007-2025
Title: The Innovative Contributions of Anne Osbourn
Introduction
Anne Osbourn is a prominent inventor based in Norwich, GB. She has made significant contributions to the field of metabolic engineering, particularly in the biosynthesis of quillaic acid. With a total of 8 patents to her name, her work has advanced the understanding and application of various biochemical processes.
Latest Patents
One of her latest patents focuses on metabolic engineering, specifically the materials and methods for biosynthesizing quillaic acid in a host. This invention involves expressing heterologous nucleotide sequences in the host, each encoding a polypeptide that collectively exhibits QA biosynthesis activity. The polypeptides include a Beta-amyrin synthase and several enzymes capable of oxidizing Beta-amyrin at various positions. Another notable patent relates to transferase enzymes, which are essential for glycosylating quillaic acid in host cells. This invention encompasses genes and polypeptides that facilitate successive glycosylation at the C-3 position of quillaic acid.
Career Highlights
Throughout her career, Anne Osbourn has worked with several notable companies, including Plant Bioscience Limited and Plant Biosciences Limited. Her expertise in metabolic engineering has positioned her as a leader in her field, contributing to advancements in biotechnology and plant sciences.
Collaborations
Anne has collaborated with esteemed colleagues such as Xiaoquan Qi and Kosmas Haralampidis. These partnerships have further enriched her research and innovation efforts.
Conclusion
Anne Osbourn's contributions to metabolic engineering and her innovative patents highlight her significant role in advancing biotechnological research. Her work continues to inspire future developments in the field.